After the selection of 10 research institutions reported stocks of concern synnex

After the selection of 10 research institutions reported stocks of concern hot column capital flows thousands of thousand shares stocks the latest Rating Rating diagnosis simulated trading client Sina App: Live on-line blogger to guide your entries you earn take can make you my guangyuyuan: ride the wind and waves will sometimes, sail sea: solve Zhejiang the history of securities debt problems, the focus of the development of traditional Chinese medicine industry: before the company has been trapped in the history of the debt problem, so Shanxi guangyuyuan never get support, can only rely on the natural slow sales growth. The company has to solve the debt problems of history at present, other industries have also been stripped of assets after the company’s development strategy has been to ZTE guangyuyuan Chinese medicine company, the leading enterprise company into Chinese manufacturing and sales of Chinese medicine cultural heritage in the field of traditional Chinese medicine, is expected to enter the high-speed development period. The core products of excellent quality, broad market space, the company is the basis of guangyuyuan quality medicine strategy at present the four main products of Guilingji, dingkundan, Angong Niuhuang Wan niuhuangqingxin pills, excellent quality, obvious curative effect, the field of broad market space, a huge space for development. Guilingji and Ding Kundan are state secrets varieties, and the company "Guilingji", "Ding Kundan" and "Angongniuhuangwan pill" has been included in the national intangible cultural heritage. The company expects 2016 Guilingji, dingkundan, Angongniuhuangwan pill, niuhuangqingxin pills and health wine growth were 122.67%, 157.15%, 67.69%, 56.61% and 133.54%. The "three carriages" strategy to reshape guangyuyuan brand: the company will continue to adhere to the "quality of traditional Chinese medicine traditional Chinese medicine + + health wine industry development strategy, in the classical Chinese medicine will be fully to the elite business platform transformation, integration of commercial channels and two terminal resources, to strengthen the academic guidance, expert team building, and actively create the turtle age set, the first brand in andrology and gynecological dingkundan; in the fine traditional Chinese medicine, Chinese medicine to promote quality of" hundreds of thousands of stores nationwide project, established 100 national medical center, 1000 Chinese medicine hall; and continue to improve the management and service level, strengthen the business development, sales training, management of the three stores sales function to promote Chinese medicine, Chinese Medicine Center Hall, overall construction; in the aspect of brand management, will continue to do a good job of product planning and market research, market promotion, media and activities Three planning functions, through online and offline activities to strengthen the company’s brand building. Earnings forecasts and Valuation: the company has to solve the debt problem, the main focus of Chinese medicine development, believe that the brand has a long history, outstanding product quality, the industry wide space in the next few years, entered a period of rapid growth of the greater probability. Forecast Ltd 2016-2018 operating income was 990 million yuan, 1 billion 869 million yuan, 3 billion 171 million yuan, an increase of respectively 131.1%, 88.81%, 69.65%; net profit attributable to the parent company (not consider the acquisition of 40% stake in Shanxi guangyuyuan) were 42 million yuan, 0.89 yuan, 153 million yuan, an increase of 1 respectively.相关的主题文章: